According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -ยฃ1.13. In 2022 the company made an earnings per share (EPS) of -ยฃ2.83 an increase over its 2021 EPS that were of -ยฃ4.29.